Progress in Neuro-Psychopharmacology and Biological Psychiatry Journal Citation Rate 2026

ISSN 0278-5846 eISSN 1878-4216 Elsevier BV US

Q1 Quartile Established Impact

About Progress in Neuro-Psychopharmacology and Biological Psychiatry
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Progress in Neuro-Psychopharmacology and Biological Psychiatry (PNBP) is a peer-reviewed academic journal covering Neuroscience and Neuropharmacology Research and Neurotransmitter Receptor Influence on Behavior, published by Elsevier BV in US, catalogued under ISSN 0278-5846 (e-ISSN 1878-4216). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 3.27 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3720 USD).

Progress in Neuro-Psychopharmacology and Biological Psychiatry Citation Rate 2026 — In Context

Progress in Neuro-Psychopharmacology and Biological Psychiatry has a 2025 2-Year Citation Rate (OpenAlex) of 3.27, placing it in the Q1 quartile within the Neuroscience and Neuropharmacology Research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Progress in Neuro-Psychopharmacology and Biological Psychiatry operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Progress in Neuro-Psychopharmacology and Biological Psychiatry should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Progress in Neuro-Psychopharmacology and Biological Psychiatry against similar journals in the field, use our journal comparison tool.

Submission Tips for Progress in Neuro-Psychopharmacology and Biological …
  • Budget $3720 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Schizophrenia research and treatment. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Progress in Neuro-Psychopharmacology … Compares
Citation Rate vs Field Avg
+7%
Field avg: 3.06
APC vs Field Avg
+10%
Field avg: $3383

Compared against 43 journals in the same research areas.

ISSN (Print) 0278-5846
ISSN (Online) 1878-4216
Publisher Elsevier BV
Country United States
APC / Cost $3720 USD
In-depth profile & metrics

Progress in Neuro-Psychopharmacology and Biological Psychiatry is published by Elsevier BV and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 3720.

In our subject taxonomy, Progress in Neuro-Psychopharmacology and Biological Psychiatry is classified under Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Schizophrenia research and treatment and Stress Responses and Cortisol.

Progress in Neuro-Psychopharmacology and Biological Psychiatry is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 3.268.

Research Areas
Links
Frequently Asked Questions about Progress in Neuro-Psychopharmacology and Biological …

Progress in Neuro-Psychopharmacology and Biological Psychiatry does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 3.268 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Progress in Neuro-Psychopharmacology and Biological Psychiatry is not an open access journal.

The Article Processing Charge (APC) for Progress in Neuro-Psychopharmacology and Biological Psychiatry is $3720 USD.

Progress in Neuro-Psychopharmacology and Biological Psychiatry is published by Elsevier BV.

Progress in Neuro-Psychopharmacology and Biological Psychiatry shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 0278-5846. Its electronic ISSN (eISSN) is 1878-4216.

Progress in Neuro-Psychopharmacology and Biological Psychiatry sits in the Q1 quartile based on its latest impact factor of 3.27, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
3.268
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 3.268 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S142279999

Get weekly updates for Neuroscience and Neuropharmacology Research journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google